Piramal Pharma Solutions (PPS) maintains its position as an international leader in the development of antibodydrug conjugates (ADCs) thanks to its vast technical knowledge, world-class staff, customer-centric approach, and integrated drug development and manufacturing programs.
Oral bioavailability is a measure of the amount of an oral administered drug dose that is absorbed in the bloodstream. Many new chemical entities (NCEs) developed in the pharmaceutical industry have poor bioavailability because of either lower solubility or extensive first-pass elimination.
The primary forces in chemistry are the electrostatic attractions between electrons and nuclei. For this reason, electrochemistry synthesis is gaining in popularity, since it inherently addresses the ways in which scientists can deal with molecules.1
Industrial cGMP peptide production has changed dramatically over the years. Today, peptide production happens on a scale that was unimaginable in the recent past, with demand driving companies to manufacture hundreds of kilograms of short chain peptides a year.
The best manufacturing site for a product can change throughout the life cycle. When bringing new drugs to market, biopharma companies may benefit from keeping production in the US to localize the supply chain and ensure the speed of delivery.
.jpg)
-1-1.png)
.png)
-2-1.png)
-3.png)
-2.png)
.png)
